Fresenius Medical Care AG & Co. KGaA FME

XET: FME | ISIN: DE0005785802   9/10/2026
37,50 EUR (+2,12%)
(+2,12%)   9/10/2026

7 oktober 2026 · Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth · Persbericht

25 september 2026 · Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership · Persbericht

27 augustus 2026 · Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis · Persbericht

3 augustus 2026 · Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda · Persbericht

3 augustus 2026 · Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery · Persbericht

29 juli 2026 · Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients · Persbericht

20 juli 2026 · Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy · Persbericht

3 juni 2026 · Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis · Persbericht

28 mei 2026 · Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million · Persbericht

27 mei 2026 · Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 · Persbericht

26 mei 2026 · Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months · Persbericht

21 mei 2026 · Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care · Persbericht

20 mei 2026 · Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer · Persbericht

5 mei 2026 · Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed · Persbericht

24 februari 2026 · Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band · Persbericht

9 januari 2026 · Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned · Persbericht

10 december 2025 · Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board · Persbericht

4 november 2025 · Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 · Persbericht

30 oktober 2025 · Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 · Persbericht

1 oktober 2025 · Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement · Persbericht

Mijn selecties